In murine experimental glioma models, TLR3 or TLR9 activation of microglial/macrophages has been shown to impair glioma growth, which could, however, not been verified in recent clinical trials. We therefore tested whether combined TLR3 and TLR9 acti-vation of microglia/macrophages would have a synergistic effect. Indeed, combined TLR3/TLR9 activation augmented the suppression of glioma growth in organotypic brain slices from male mice in a microglia-dependent fashion, and this synergistic suppression depended on interferon b release and phagocytic tumor clearance. Combined TLR3/TLR9 stimulation also augmented several func-tional features of microglia, such as the release of proinflammatory factors, motility, and phagocytosis activity. TLR3/TLR9 stimulation combined with CD47 blockade further augmented glioma clearance. Finally, we confirmed that the coactivation of TLR3/TLR9 also augments the impairment of glioma growth in vivo. Our results show that combined activation of TLR3/TLR9 in microglia/macro-phages results in a more efficient glioma suppression, which may provide a potential strategy for glioma treatment.
基金:
Einstein-Stiftung; Helmholtz-Gemeinschaft, Zukunftsthema Immunology and Inflammation [ZT-0027]; National Natural Science Foundation of China [81602202]; China Scholarship Council; Medical Neuroscience graduate program of Charite, Berlin; Berlin Institute of Health